TEVA-TRIMEL DS 800 MG — DIN 00510645
SULFAMETHOXAZOLE : 800 MG TRIMETHOPRIM : 160 MG · TEVA CANADA LIMITED · TABLET · wholesale supply in Canada
Health Canada status: DORMANT
What is TEVA-TRIMEL DS?
TEVA-TRIMEL DS 800 MG contains SULFAMETHOXAZOLE : 800 MG TRIMETHOPRIM : 160 MG. It is listed in the Health Canada Drug Product Database under DIN 00510645, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 14-May-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
What is TEVA-TRIMEL DS used for?
Infections caused by susceptible organisms: UTIs, acute exacerbations of chronic bronchitis, Pneumocystis jiroveci pneumonitis, cholera (adjunct), and second-line for brucellosis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Sulfamethoxazole And Trimethoprim cost around the world?
Sulfamethoxazole And Trimethoprim is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max); Czechia publishes a max producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 29 | 54 | ZAR███.██ |
| Saudi Arabia | public | 29 | 34 | SAR███.██ |
| Czechia | max producer price (ex-factory) | 3 | 6 | CZK███.██ |
| Austria | KVP (Kassenverkaufspreis) | 3 | 5 | EUR███.██ |
| Bahrain | retail (max) | 5 | 5 | BHD███.██ |
| Luxembourg | reimbursement | 5 | 5 | EUR███.██ |
| United Arab Emirates | public | 2 | 4 | AED███.██ |
113 pack listings across 76 brand entries and 6 price bases, refreshed 05 Sep 2026. Ranges span every Sulfamethoxazole And Trimethoprim pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Sulfamethoxazole And Trimethoprim in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
15 holders have a Canadian DIN containing Sulfamethoxazole And Trimethoprim, across 31 DINs, of which 6 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 3 | 3 | SULFATRIM, SULFATRIM DS, SULFATRIM PEDIATRIC | Sourceable in Canada |
| ASPEN PHARMACARE CANADA INC. | 2 | 1 | SEPTRA INJECTION, SEPTRA PEDIATRIC SUSPENSION | Sourceable in Canada |
| AURO PHARMA INC | 1 | 1 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Sourceable in Canada |
| EUGIA PHARMA INC. | 1 | 1 | SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | Sourceable in Canada |
| HOFFMANN-LA ROCHE LIMITED | 4 | 0 | BACTRIM DS ROCHE TAB, BACTRIM ROCHE INJ, BACTRIM ROCHE SUSPENSION PAEDIATRIC, BACTRIM ROCHE TAB | No marketed DIN |
| JAAPHARM CANADA INC. | 3 | 0 | TRISULFA DS TAB, TRISULFA S SUSPENSION, TRISULFA TAB | No marketed DIN |
| NU-PHARM INC | 3 | 0 | NU-COTRIMOX SUS 40/8MG/ML, NU-COTRIMOX TAB 400/80MG, NU-COTRIMOX-DS TAB 800/160MG | No marketed DIN |
| TEVA CANADA LIMITED | 3 | 0 | TEVA-TRIMEL, TEVA-TRIMEL DS | No marketed DIN |
| D.C. LABS LIMITED | 2 | 0 | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS | No marketed DIN |
| GLAXOSMITHKLINE INC | 2 | 0 | SEPTRA, SEPTRA DS TABLETS | No marketed DIN |
| PRO DOC LIMITEE | 2 | 0 | PROTRIN DF TAB, PROTRIN TAB | No marketed DIN |
| ROUGIER PHARMA DIVISION OF RATIOPHARM INC | 2 | 0 | ROUBAC TAB 160/800, ROUBAC TAB 80/400 | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 800 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Not explicitly detailed in provided text (mentions Tablets, DS Tablets, and Oral Suspension). |
| Storage | Not explicitly detailed in provided text (standard practice is 15-30°C). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Sulfamethoxazole And Trimethoprim |
|---|---|
| ATC code | J01EE01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00510645 |
|---|---|
| DIN (unpadded, as printed on some documents) | 510645 |
| Brand name | TEVA-TRIMEL DS |
| Generic / active ingredient | SULFAMETHOXAZOLE : 800 MG TRIMETHOPRIM : 160 MG |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | J01EE01 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01EE |
| Current status | DORMANT |
| Status date | 14-May-2021 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Dosage should be adjusted for renal function. Maintain adequate urinary output. Specific doses for PJP and cholera mentioned. See full monograph for detailed weight-based/infection-specific dosing.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to trimethoprim or sulfonamides; megaloblastic anemia due to folate deficiency; marked liver damage; blood dyscrasias; marked renal impairment; pregnancy; nursing; infants <2 months.
Warnings and precautions
Fatalities from SJS, TEN, fulminant hepatic necrosis, and blood dyscrasias. Discontinue at first sign of rash. Risk of Clostridium difficile-associated disease (CDAD) and hyperkalemia.
Is Sulfamethoxazole And Trimethoprim in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AURO PHARMA INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
6 of 31 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| SEPTRA INJECTION | 16 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | MARKETED | 00550086 |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | 16 MG | SOLUTION | AURO PHARMA INC | MARKETED | 02525917 |
| SULFAMETHOXAZOLE AND TRIMETHOPRIM FOR INJECTION, USP | 80 MG | SOLUTION | EUGIA PHARMA INC. | MARKETED | 02534746 |
| SULFATRIM | 80 MG | TABLET | AA PHARMA INC | MARKETED | 00445274 |
| SULFATRIM DS | 800 MG | TABLET | AA PHARMA INC | MARKETED | 00445282 |
| SULFATRIM PEDIATRIC | 100 MG | TABLET | AA PHARMA INC | MARKETED | 00445266 |
| APO-SULFATRIM ORAL SUSPENSION | 40 MG | SUSPENSION | APOTEX INC | CANCELLED POST MARKET | 00846465 |
| BACTRIM DS ROCHE TAB | 160 MG | TABLET | HOFFMANN-LA ROCHE LIMITED | CANCELLED POST MARKET | 00371823 |
| BACTRIM ROCHE INJ | 80 MG | LIQUID | HOFFMANN-LA ROCHE LIMITED | CANCELLED POST MARKET | 00550078 |
| BACTRIM ROCHE SUSPENSION PAEDIATRIC | 40 MG / 5 ML | SUSPENSION | HOFFMANN-LA ROCHE LIMITED | CANCELLED POST MARKET | 00272485 |
2 · Same class — other molecules in ATC J01EE
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Sulfamethoxazole And Trimethoprim | APO-SULFATRIM ORAL SUSPENSION · BACTRIM DS ROCHE TAB · BACTRIM ROCHE INJ · BACTRIM ROCHE SUSPENSION PAEDIATRIC · +24 more | 31 | 6 | Yes |
| Sulfadiazine And Trimethoprim | COPTIN ORAL SUSPENSION · COPTIN TAB | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01E
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01EA | Trimethoprim | 4 | 2 |
| J01EB | Sulfafurazole · Sulfamethizole · Sulfapyridine | 5 | 0 |
| J01EC | Sulfadiazine · Sulfamethoxazole | 3 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TEVA-TRIMEL DS called?
The same molecule, Sulfamethoxazole And Trimethoprim, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Ilvitrim | Latin | South Africa |
| Ultrasept | Latin | South Africa |
| BISEPTOL | Latin | Czechia |
| Co-Trim | Latin | South Africa |
| Purbac Ds | Latin | South Africa |
| Spectrim | Latin | South Africa |
| Xerazole Suspension | Latin | South Africa |
| Bactrim | Latin | South Africa |
| Bactrim Ds | Latin | South Africa |
| COTRIMOXAZOL AL FORTE | Latin | Czechia |
| Dynazole | Latin | South Africa |
| Eusaprim forte Tabl. | Latin | Austria |
| Eusaprim Kindersusp. | Latin | Austria |
| Merck-Co-trimoxazole Paediatric | Latin | South Africa |
| Novatrim | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.